BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 1781103)

  • 1. Oncogenes and growth factors in renal cell carcinoma.
    Peter S
    Urol Int; 1991; 47(4):199-202. PubMed ID: 1781103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Significance of oncogenes and growth factors in hypernephroma].
    Peter S
    Urologe A; 1992 Jan; 31(1):24-7. PubMed ID: 1553800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Overexpression of c-myc, c-fos and Harvey ras oncogenes in renal cancers--analysis at the messenger RNA levels].
    Kunimi K; Uchibayashi T; Hisazumi H
    Nihon Hinyokika Gakkai Zasshi; 1991 Dec; 82(12):1924-9. PubMed ID: 1779495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Infrequent ras oncogene point mutations in renal cell carcinoma.
    Nanus DM; Mentle IR; Motzer RJ; Bander NH; Albino AP
    J Urol; 1990 Jan; 143(1):175-8. PubMed ID: 2403598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inverse relationship of epidermal growth factor receptor and HER2/neu gene expression in human renal cell carcinoma.
    Weidner U; Peter S; Strohmeyer T; Hussnätter R; Ackermann R; Sies H
    Cancer Res; 1990 Aug; 50(15):4504-9. PubMed ID: 1973362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of pro-epidermal growth factor, pro-transforming growth factor alpha and epidermal growth factor receptor gene expression in human renal carcinomas.
    Petrides PE; Bock S; Bovens J; Hofmann R; Jakse G
    Cancer Res; 1990 Jul; 50(13):3934-9. PubMed ID: 2354442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proto-oncogenes and tumor suppressor genes in human urological malignancies.
    Strohmeyer TG; Slamon DJ
    J Urol; 1994 Jun; 151(6):1479-97. PubMed ID: 8189554
    [No Abstract]   [Full Text] [Related]  

  • 8. Gene expression profiling of renal cell carcinoma: a DNA macroarray analysis.
    Lovisolo JA; Casati B; Clerici L; Marafante E; Bono AV; Celato N; Salvadore M
    BJU Int; 2006 Jul; 98(1):205-16. PubMed ID: 16831170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic vulnerabilities of MYC-induced cancer.
    Gouw AM; Toal GG; Felsher DW
    Oncotarget; 2016 May; 7(21):29879-80. PubMed ID: 26863454
    [No Abstract]   [Full Text] [Related]  

  • 10. Oncogene and HSP-70 expression in primary tumor cell cultures of renal cell carcinoma compared to their corresponding cell line.
    Köhler G; Veelken H; Rosenthal F; Mackensen A; Lindemann A; Schaefer HE; Lahn M
    Anticancer Res; 1997; 17(5A):3225-31. PubMed ID: 9413152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of the human fes cellular oncogene in renal cell tumors.
    Karthaus HF; Schalken JA; Feitz WF; Debruyne FM; de Haan PT; Bloemers HP; Van de Ven WJ
    Urol Res; 1986; 14(3):123-7. PubMed ID: 3018974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Renal cell cancer: oncogenes and tumor suppressor genes].
    Dietrich PY; Droz JP
    Rev Prat; 1992 May; 42(10):1236-40. PubMed ID: 1609216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigation of c-myc and K-ras amplification in renal clear cell adenocarcinoma.
    Kozma L; Kiss I; Nagy A; Szakáll S; Ember I
    Cancer Lett; 1997 Jan; 111(1-2):127-31. PubMed ID: 9022137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oncogenes in prostate cancer. An update.
    Peehl DM
    Cancer; 1993 Feb; 71(3 Suppl):1159-64. PubMed ID: 8428339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression and amplification of c-myc in the Syrian hamster kidney during estrogen carcinogenesis: a probable critical role in neoplastic transformation.
    Li JJ; Hou X; Banerjee SK; Liao DZ; Maggouta F; Norris JS; Li SA
    Cancer Res; 1999 May; 59(10):2340-6. PubMed ID: 10344741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation between successful heterotransplantation of lung tumors in nude mice, poor prognosis of patients and expression of Fos, Jun, ErbB1, and Ras.
    Volm M; Mattern J
    Anticancer Res; 1993; 13(6A):2021-5. PubMed ID: 8297109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of epidermal growth factor receptor by activated H-ras and V-myc oncogenes in mouse Balb/3T3 cells: possible roles of AP-1.
    Okimoto T; Kohno K; Kuwano M; Gopas J; Kung HF; Ono M
    Oncogene; 1996 Apr; 12(8):1625-33. PubMed ID: 8622882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of DNA sequences on chromosome 3 in renal cell carcinoma.
    Linehan WM; Zbar B
    Urology; 1987 Oct; 30(4):404. PubMed ID: 3660534
    [No Abstract]   [Full Text] [Related]  

  • 19. Cytogenetic, molecular and phenotypic characterization of the newly established renal carcinoma cell line KJ29. Evidence of translocations for chromosomes 1 and 3.
    Barletta C; Bartolazzi A; Cimino Reale G; Gambari R; Nastruzzi C; Barbieri R; Del Senno L; Castagnoli A; Natali PG
    Anticancer Res; 1995; 15(5B):2129-36. PubMed ID: 8572614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular genetics of renal cell carcinoma.
    Vignoli GC; Martorana G
    Arch Ital Urol Androl; 1997 Sep; 69(4):265-9. PubMed ID: 9396188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.